We are live on ! Find out more
AAP

Ardsley Advisory Partners Portfolio holdings

AUM $960M
1-Year Est. Return 207.76%
This Fund
S&P 500
This Quarter Est. Return
+8.17%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$719M
AUM Growth
+$88.4M
Cap. Flow
+$57.2M
Cap. Flow %
7.96%
Top 10 Hldgs %
33.35%
Holding
285
New
104
Increased
39
Reduced
27
Closed
96

Top Buys

Rank Stock Value
1
VC icon
Visteon
VC
+$16.2M
2
CELG
Celgene Corp
CELG
+$15M
3
TERP
TerraForm Power, Inc
TERP
+$13.3M
4
META icon
Meta Platforms (Facebook)
META
+$12.2M
5
TWTR
Twitter, Inc.
TWTR
+$12.2M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$17.7M
2
C icon
Citigroup
C
+$16.2M
3
FFIV icon
F5
FFIV
+$14.4M
4
HDS
HD Supply Holdings, Inc.
HDS
+$12.7M
5
URI icon
United Rentals
URI
+$12.2M

Sector Composition

Rank Sector Weight
1 Healthcare 25.14%
2 Technology 12.74%
3 Real Estate 7.06%
4 Consumer Discretionary 5.54%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CORV
176
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$139K 0.02%
+15,000
New +$144K
BLDR icon
177
Builders FirstSource
BLDR
$7.93B
$133K 0.02%
+20,000
New +$125K
OSUR icon
178
OraSure Technologies
OSUR
$277M
$131K 0.02%
+20,000
New +$166K
XOMA
179
DELISTED
Xoma
XOMA
$127K 0.02%
1,750
+500
+40% +$36.7K
GNCA
180
DELISTED
Genocea Biosciences, Inc.
GNCA
$119K 0.02%
+1,250
New +$88.2K
CDXS icon
181
Codexis
CDXS
$161M
$114K 0.02%
+25,000
New +$88.2K
CASM
182
DELISTED
CAS Medical Systems, Inc.
CASM
$113K 0.02%
+85,000
New +$122K
ALIM
183
DELISTED
Alimera Sciences
ALIM
$100K 0.01%
1,333
– –
BCRX icon
184
BioCryst Pharmaceuticals
BCRX
$2.48B
$90K 0.01%
+10,000
New +$104K
LCTX icon
185
Lineage Cell Therapeutics
LCTX
$267M
$75K 0.01%
+18,585
New +$64.3K
OPCH icon
186
CALL
Option Care Health
OPCH
$3.53B
$44K 0.01%
+2,500
New +$54.6K
TLPH icon
187
Talphera
TLPH
$67.5M
$39K 0.01%
500
– –
PRPO icon
188
Precipio
PRPO
$40.5M
$36K 0.01%
+3
New +$58.3K
ARCT icon
189
Arcturus Therapeutics
ARCT
$163M
– –
-2,143
Closed -$56K
ASYS icon
190
Amtech Systems
ASYS
$257M
– –
-28,400
Closed -$290K
AWI icon
191
Armstrong World Industries
AWI
$7.55B
– –
-12,500
Closed -$639K
DCH
192
Dauch Corp
DCH
$1.33B
– –
-30,000
Closed -$678K
AYI icon
193
Acuity Brands
AYI
$10.3B
– –
-9,800
Closed -$1.37M
BABA icon
194
Alibaba
BABA
$276B
– –
-170,000
Closed -$17.7M
BAC icon
195
CALL
Bank of America
BAC
$439B
– –
-1,070,000
Closed -$19.1M
BBY icon
196
CALL
Best Buy
BBY
$18.9B
– –
-30,000
Closed -$1.17M
BSX icon
197
Boston Scientific
BSX
$68.5B
– –
-15,000
Closed -$199K
BWA icon
198
BorgWarner
BWA
$13B
– –
-25,560
Closed -$1.24M
BWEN icon
199
Broadwind
BWEN
$92.9M
– –
-34,500
Closed -$186K
C icon
200
CALL
Citigroup
C
$222B
– –
-50,000
Closed -$2.71M
6 7
8
9 10

Similar funds

NA
Navellier & Associates Reno, Nevada $960M AUM 79.37% 1-Year Est. Return
MK
MASTERINVEST Kapitalanlage Vienna $962M AUM 27.59% 1-Year Est. Return
QIM
Quantitative Investment Management Charlottesville, Virginia $963M AUM 12.95% 1-Year Est. Return
JVBC
J.V. Bruni & Co Colorado Springs, Colorado $958M AUM 22.2% 1-Year Est. Return
TFP
Triple Frond Partners San Francisco, California $963M AUM 27.45% 1-Year Est. Return
UWPG
Ullmann Wealth Partners Group Jacksonville Beach, Florida $963M AUM 17.06% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
PHS
Pekin Hardy Strauss Chicago, Illinois $957M AUM 44.61% 1-Year Est. Return

Ardsley Advisory Partners's Q1 2015 Portfolio in Review

As of Q1 2015, Ardsley Advisory Partners held 285 positions worth $719M, up 14% from $631M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ardsley Advisory Partners deployed $57.2M of net new capital in Q1 2015, opening 104 new positions and adding to 39 existing holdings. Its largest new stake was TerraForm Power, Inc: 403,000 shares worth $14.7M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 25% a quarter earlier, followed by Technology and Real Estate.

On the sell side, the largest reduction was Supernus Pharmaceuticals, an estimated $8.59M trimmed.

  • Ardsley Advisory Partners's largest Q1 2015 buy was TerraForm Power, Inc: 403,000 shares worth $14.7M.
  • Ardsley Advisory Partners added most to Visteon in Q1 2015, an estimated $16.2M increase.
  • Ardsley Advisory Partners's biggest Q1 2015 reduction was Supernus Pharmaceuticals, cutting an estimated $8.59M.
  • Ardsley Advisory Partners fully exited Alibaba in Q1 2015, selling an estimated $17.7M.
  • Ardsley Advisory Partners's ten largest holdings make up 33% of its $719M portfolio in Q1 2015.
  • Ardsley Advisory Partners opened 104 new positions and closed 96 in Q1 2015.
  • Ardsley Advisory Partners's portfolio value rose 14% quarter-over-quarter to $719M.

Based on Ardsley Advisory Partners's 13F filing for Q1 2015, filed 15 May 2015.